Chemical & Pharmaceutical

Sinopec and Sibur to Produce Rubber in Krasnoyarsk

Posted on by

May 15 – China Petroleum and Chemical Corporation (Sinopec) and Sibur, the Russian petrochemicals group, have entered into a cooperation agreement to form a butadiene nitrile rubber joint venture in the Siberian city of Krasnoyarsk.

The cooperation deal was signed by Sibur’s CEO Dmitry Konov and Sinopec’s president Wang Tianpu at the recent Russian-Chinese Forum on commercial investment cooperation in Moscow.

The cooperation agreement includes a mechanism for the financing of the joint venture, and arrangements relating to share capital, management, raw material supplies and marketing. Continue reading…

Radioactive Iodine Found in Russia’s Primorye Region

Posted on by

Mar. 31 – Traces of radioactive iodine-131 from Japan have been found in Russia’s Primorye region, the head of the local meteorological service, Boris Bulai, said on its web site.

“Its concentration is more than 100 times lower than the acceptable level, and thus presents no threat to people’s health,” he said.

Primorye is the southeasternmost region of Russia bordered by China, North Korea, and it also verges on the sea with Japan. Continue reading…

American 3M to Expand into Russian Regions

Posted on by

Mar. 23 – The U.S. industrial conglomerate 3M, formerly known as the Minnesota Mining and Manufacturing Company, plans to build local facilities in Russia’s Tyumen and Samara regions. The total investment is expected to be more than US$15 million, Reza Vaziri, 3M Russia chief said Tuesday to reporters.

The company’s facility in Tyumen will produce an insulation material Thinsulate — a very thin synthetic fiber thermal insulation fabric used in clothing. The other one in Samara will make glass bubbles used as an additive to cement that fortifies oil and gas wells. Continue reading…

Global Drug Makers to Manufacture in Russia

Posted on by

Feb. 9 – More global drug makers will soon announce plans to establish a local presence in Russia in response to government measures to boost its domestic sector and cut dependence on imports, industry group Association of International Pharmaceutical Manufacturers (AIPM) said on Tuesday.

AIPM, whose members account for 80 percent of all global drug sales, had earlier promised US$1 billion in investments in Russian manufacturing, packaging and research and development. Continue reading…

Foreign Investment Commission Approves Plant, Oil and Gold Mine Deals

Posted on by

Apr. 14 – Prime Minister Vladimir Putin and the government’s foreign investment commission on Tuesday approved a deal to sell a private insulin plant to Europe’s biggest drug maker, France-based Sanofi-Aventis.

The plant was bought in Oct 2009 from Bioton Vostok in Oryol region of Russian Federation which lies in 382 kilometers to the south of Moscow, in the European part of Russia.

Putin singled out the planned French investment as particularly noteworthy. “Among these, I want to point out one project that is not big but is significant, in my view,” he said, referring to Sanofi’s intention to buy 74 percent of the Bioton Vostok plant in Oryol. Continue reading…

Never Miss an Update

Subscribe to gain even better insights into doing business in Russia. Subscribing also lets you to take full advantage of all our website features including customizable searches, favorite, wish list and gift functions and access to otherwise restricted content.

Scroll to top